Nicotine metabolism and elimination kinetics in newborns

Clinical Pharmacology and Therapeutics

Volumn 67, Issue 5, 2000, Pages 458-465

  Dempsey, Delia ^a   Jacob III, Peyton ^a   Benowitz, Neal L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; NICOTINE;

ARTICLE; CLINICAL ARTICLE; DRUG ELIMINATION; DRUG HALF LIFE; ENZYME SUBSTRATE COMPLEX; FETOMATERNAL TRANSFUSION; HUMAN; NEWBORN; PRIORITY JOURNAL; SMOKING;

EID: 0034038525     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2000.106129     Document Type: Article

References (28)

1. 1. Ventura SJ, Martin JA, Taffel SM. Advanced report of final natality statistics. Month Vital Stat Report 1995;44:1-88.
2. 2. Henningfield JE, Benowitz NL. Cigarettes and addiction. Br Med J 1995;310:1082-3.
3. 3. Benowitz NL. Pharmacology of nicotine: addiction and therapeutics. Annu Rev Pharmacol Toxicol 1996;36:597-613.
4. 4. Donnenfeld AE, Pulkkinen A, Palomaki GE, Knight GJ, Haddow JE. Simultaneous fetal and maternal cotinine levels in pregnant women smokers. Am J Obstet Gynecol 1993;168:781-2.
5. 5. Benowitz NL, Jacob P, III, Fong I, Gupta S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther 1994; 268:296-303.
6. 6. Messina ES, Tyndale RF, Sellers EM. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther 1997;282:1608-14.
7. 7. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, et al. Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsomes. J Pharmacol Exp Ther 1996;277:1010-5.
8. 8. Hakkola J, Pasanen M, Purkunen R, Saarikoski S, Pelkonen O, Maenpaa J, et al. Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol 1994;48:59-64.
9. 9. Leeder JG, Kearns GL. Pharmacogenetics in pediatrics: implications for practice. Pediatr Clin North Am 1997;44: 55-77.
10. 10. Department of Health and Human Services PHS. Healthy People 2000 (Stock No. 017-001-00474-0), Food and Drug Administration Modernization Act of 1997, Pub L 105-115, 21 U.S.C. 335a(b), 11/21/97. Washington (DC): US Government Printing Office; 1997.
11. 11. Reed MD, Besunder JB. Developmental pharmacology: ontogenic basis of drug disposition. Pediatr Clin North Am 1989;36:1053-74.
12. 12. Treluyer JM, Gueret G, Cheron G, Sonnier M, Cresteil T. Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in vivo/in vitro correlation and inducibility. Pharmacogenetics 1997;7:441-52.
13. 13. Kitada M, Taneda M, Itahashi K, Kamataki T. Four forms of cytochrome P-450 in human fetal liver: purification and their capacity to activate promutagens. Jpn J Cancer Res 1991;82:426-32.
14. 14. Lacroix D, Sonnier M, Moncion A, Cheron G, Cresteil T. Expression of CYP3A in the human liver: evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 1997;247:625-34.
15. 15. Tateishi T, Nakura H, Asoh M, Watanabe M, Tanaka M, Kumai T, et al. A comparison of hepatic cytochrome P450 protein expression between infancy and postinfancy. Life Sci 1997;61:2567-74.
16. 16. Dempsey DA, Partridge JC, Jones RT, Rowbotham MC. Cocaine, nicotine, caffeine and metabolite plasma concentrations in neonates. J Anal Toxicol 1998;22:220-4.
17. 2 in humans. Biol Mass Spectrom 1991;20:247-52.
18. 18. Jacob P III, Yu L, Liang G, Shulgin AT, Benowitz NL. Gas chromatographic-mass spectrometric method for determination of anabasine, anatabine and other tobacco alkaloids in urine of smokers and smokeless tobacco users. J Chromatogr Biomed Appl 1993;619:49-61.
19. 19. NONMEM Project Group. NONMEM users guide. San Francisco (CA): University of California, San Francisco; 1992.
20. 20. Etzel RA, Greenberg RA, Haley NJ, Loda FA. Urine cotinine excretion in neonates exposed to tobacco smoke products in utero. J Pediatr 1985;107:146-8.
21. 21. Benowitz NL, Jacob P III. Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers. Clin Pharmacol Ther 1993;53:316-23.
22. 22. Fried PA, Perkins SL, Watkinson B, McCartney JS. Association between creatinine-adjusted and unadjusted urine cotinine values in children and the mother's report of exposure to environmental tobacco smoke. Clin Biochem 1995;28:415-20.
23. 23. Guignard JP. Measurement of glomerular filtration rate in neonates. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology; vol 2. Philadelphia: WB Saunders; 1988. p. 1593-9.
24. 24. Benowitz NL, Jacob P III. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther 1994;56:483-93.
25. 25. Flammang AM, Gelboin HV, Aoyama T, Gonzalez FJ, McCoy GD. Nicotine metabolism by cDNA-expressed human cytochrome P-450s. Biochem Arch 1992;8:1-8.
26. 26. McCracken NW, Cholerton S, Idle JR. Cotinine formation by cDNA-expressed human cytochromes P450. Med Sci Res 1992;20:877-8.
27. 27. Benowitz NL, Jacob P III, Perez-Stable E. CYP2D6 phenotype and the metabolism of nicotine and cotinine. Pharmacogenetics 1996;6:239-42.
28. 28. Benowitz NL, Perez-Stable EJ, Fong I, Modin G, Herrera B, Jacob P III. Ethnic differences in N-glucuronidation of nicotine and cotinine. J Pharmacol Exp Ther 1999;291: 1196-203.